Responsible patient advocacy: Perspectives from the alpha-1 foundation

Richard R. Sharp, Mark A Yarborough, John W. Walsh, Marilyn Coors, Shirley Dennis, Eric Juengst, Jennifer Longstaff, Jon Merz, Ray Moseley, Connie Stockham, Richard Sharp, Debbie Waldrop, Adam Wanner, Rob Williams, Mark Yarborough

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Patient advocacy groups play an increasingly prominent role in patient care and clinical research. To help manage some of the unique challenges associated with the involvement of patient-centered organizations in the delivery of medical services and conduct of clinical research, patient advocacy groups may wish to establish an ethics advisory board. Although hospitals and government agencies often adopt this approach, ethics advisory boards have not been widely used by patient advocacy groups. We report on the experiences of an ethics advisory board for a patient advocacy group actively involved in genetic testing and clinical research. Drawing on the experiences of this organization, we examine the potential advantages and limitations of this approach to navigating the complex moral terrain of contemporary medicine and biomedical research.

Original languageEnglish (US)
Pages (from-to)2845-2850
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume146
Issue number22
DOIs
StatePublished - Nov 15 2008
Externally publishedYes

Fingerprint

Patient Advocacy
Ethics
Research
Organizations
Government Agencies
Genetic Testing
Biomedical Research
Patient Care
Medicine

Keywords

  • Alpha-1 antitrypsin
  • Ethics advisory board
  • Health policy
  • Patient advocacy

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Sharp, R. R., Yarborough, M. A., Walsh, J. W., Coors, M., Dennis, S., Juengst, E., ... Yarborough, M. (2008). Responsible patient advocacy: Perspectives from the alpha-1 foundation. American Journal of Medical Genetics, Part A, 146(22), 2845-2850. https://doi.org/10.1002/ajmg.a.32558

Responsible patient advocacy : Perspectives from the alpha-1 foundation. / Sharp, Richard R.; Yarborough, Mark A; Walsh, John W.; Coors, Marilyn; Dennis, Shirley; Juengst, Eric; Longstaff, Jennifer; Merz, Jon; Moseley, Ray; Stockham, Connie; Sharp, Richard; Waldrop, Debbie; Wanner, Adam; Williams, Rob; Yarborough, Mark.

In: American Journal of Medical Genetics, Part A, Vol. 146, No. 22, 15.11.2008, p. 2845-2850.

Research output: Contribution to journalArticle

Sharp, RR, Yarborough, MA, Walsh, JW, Coors, M, Dennis, S, Juengst, E, Longstaff, J, Merz, J, Moseley, R, Stockham, C, Sharp, R, Waldrop, D, Wanner, A, Williams, R & Yarborough, M 2008, 'Responsible patient advocacy: Perspectives from the alpha-1 foundation', American Journal of Medical Genetics, Part A, vol. 146, no. 22, pp. 2845-2850. https://doi.org/10.1002/ajmg.a.32558
Sharp, Richard R. ; Yarborough, Mark A ; Walsh, John W. ; Coors, Marilyn ; Dennis, Shirley ; Juengst, Eric ; Longstaff, Jennifer ; Merz, Jon ; Moseley, Ray ; Stockham, Connie ; Sharp, Richard ; Waldrop, Debbie ; Wanner, Adam ; Williams, Rob ; Yarborough, Mark. / Responsible patient advocacy : Perspectives from the alpha-1 foundation. In: American Journal of Medical Genetics, Part A. 2008 ; Vol. 146, No. 22. pp. 2845-2850.
@article{7d4979c4bf98480b86c9f17278db66ea,
title = "Responsible patient advocacy: Perspectives from the alpha-1 foundation",
abstract = "Patient advocacy groups play an increasingly prominent role in patient care and clinical research. To help manage some of the unique challenges associated with the involvement of patient-centered organizations in the delivery of medical services and conduct of clinical research, patient advocacy groups may wish to establish an ethics advisory board. Although hospitals and government agencies often adopt this approach, ethics advisory boards have not been widely used by patient advocacy groups. We report on the experiences of an ethics advisory board for a patient advocacy group actively involved in genetic testing and clinical research. Drawing on the experiences of this organization, we examine the potential advantages and limitations of this approach to navigating the complex moral terrain of contemporary medicine and biomedical research.",
keywords = "Alpha-1 antitrypsin, Ethics advisory board, Health policy, Patient advocacy",
author = "Sharp, {Richard R.} and Yarborough, {Mark A} and Walsh, {John W.} and Marilyn Coors and Shirley Dennis and Eric Juengst and Jennifer Longstaff and Jon Merz and Ray Moseley and Connie Stockham and Richard Sharp and Debbie Waldrop and Adam Wanner and Rob Williams and Mark Yarborough",
year = "2008",
month = "11",
day = "15",
doi = "10.1002/ajmg.a.32558",
language = "English (US)",
volume = "146",
pages = "2845--2850",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "22",

}

TY - JOUR

T1 - Responsible patient advocacy

T2 - Perspectives from the alpha-1 foundation

AU - Sharp, Richard R.

AU - Yarborough, Mark A

AU - Walsh, John W.

AU - Coors, Marilyn

AU - Dennis, Shirley

AU - Juengst, Eric

AU - Longstaff, Jennifer

AU - Merz, Jon

AU - Moseley, Ray

AU - Stockham, Connie

AU - Sharp, Richard

AU - Waldrop, Debbie

AU - Wanner, Adam

AU - Williams, Rob

AU - Yarborough, Mark

PY - 2008/11/15

Y1 - 2008/11/15

N2 - Patient advocacy groups play an increasingly prominent role in patient care and clinical research. To help manage some of the unique challenges associated with the involvement of patient-centered organizations in the delivery of medical services and conduct of clinical research, patient advocacy groups may wish to establish an ethics advisory board. Although hospitals and government agencies often adopt this approach, ethics advisory boards have not been widely used by patient advocacy groups. We report on the experiences of an ethics advisory board for a patient advocacy group actively involved in genetic testing and clinical research. Drawing on the experiences of this organization, we examine the potential advantages and limitations of this approach to navigating the complex moral terrain of contemporary medicine and biomedical research.

AB - Patient advocacy groups play an increasingly prominent role in patient care and clinical research. To help manage some of the unique challenges associated with the involvement of patient-centered organizations in the delivery of medical services and conduct of clinical research, patient advocacy groups may wish to establish an ethics advisory board. Although hospitals and government agencies often adopt this approach, ethics advisory boards have not been widely used by patient advocacy groups. We report on the experiences of an ethics advisory board for a patient advocacy group actively involved in genetic testing and clinical research. Drawing on the experiences of this organization, we examine the potential advantages and limitations of this approach to navigating the complex moral terrain of contemporary medicine and biomedical research.

KW - Alpha-1 antitrypsin

KW - Ethics advisory board

KW - Health policy

KW - Patient advocacy

UR - http://www.scopus.com/inward/record.url?scp=56049118019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56049118019&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.32558

DO - 10.1002/ajmg.a.32558

M3 - Article

C2 - 18932220

AN - SCOPUS:56049118019

VL - 146

SP - 2845

EP - 2850

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 22

ER -